Skip To Main Content
Michael J Peluso on Muck Rack

Michael J Peluso

As seen in: Forbes, Nature, Wiley Online Library, PLOS ONE, ScienceDirect, MDPI, Science Magazine, BioRxiv, Cell Press, The Lancet and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael J

Contact Michael J, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Expansion of stemlike HIV-specific CD8 + T cells and limited viral epitope diversity characterize durable posttreatment control of HIV

|
By Ruizeng Yang, Naseeb Kaur Malhi, Alessandro Umbach, Charles Crain, Aljawharah Alrubayyi, Itai Muzhingi, Rinki Deo, Prerana Shrestha, Behzad Etemad, Hannah Macleod Verified, Gregory M Laird, Manish C. Choudhary, Michael J Peluso, Steve Deeks Verified, Anna Traunbauer, Esther Jeon, Efthimios A. Deligiannidis
| Science Magazine Verified
Editor’s summary A subset of people living with HIV (PLWH) exhibit sustained control of the virus even after stopping antiretroviral therapy (ART). Here, Crain et al. investigated how the immune responses in these individuals differed from those of noncontrollers. They found that HIV-specific CD8+ T cell responses exhibit robust expansion and a stemlike phenotype in individuals who maintained posttreatment control.
Open in Who Shared Issue with article?

COVID-19-associated neurological and psychological manifestations

|
By Jo Wilson, Deepti Gurdasani, Raimund Helbok, Serefnur Ozturk, Douglas Fraser, Saša R Filipović, Michael J Peluso, Akiko Iwasaki, Clarissa Lin Yasuda, Tommaso Bocci, Alberto Priori, Daniel M. Altmann, Nisreen A Alwan, E. Wesley Ely
| Nature Verified
Abstract Long COVID is an infection-associated chronic condition that typically occurs within 3 months of acute COVID-19 infection in which symptoms are intermittently or continuously present for at least 3 months. Long COVID is estimated to affect between 80 and 400 million people globally, with an incidence of 5–20% in the community and up to 50% among hospitalized patients following acute SARS-CoV-2 infection.
Open in Who Shared Issue with article?

A systematic review and meta-analysis of the impact of vaccination on prevention of long COVID - Nature Communications

|
By Rhiannon Green, AMITAVA BANERJEE, Brendan Delaney, Michael J Peluso
| Nature Verified
Abstract Long COVID affects millions worldwide and its prevention is a critical public health strategy. While prior analyses show primary vaccination prevents long COVID in subsequent infections, the effect of booster vaccination on long COVID after Omicron infections is unclear. This systematic review identifies 31 observational studies, of which 11 are suitable for pairwise meta-analyses.
Open in Who Shared Issue with article?
See all 52 licensed articles (53 Total)